A simple blood test that could exclude pulmonary thromboembolism would have obvious appeal. Not only would it reduce the number of ventilation and perfusion scans performed, but more importantly it would reduce inappropriate anticoagulation.
Monoclonal antibodies to a neoantigen produced by proteolysis ofcross-linked fibrin have been produced. Both an enzyme linked immunosorbent assay and a latex agglutination test are now commercially available and have the potential for detecting intravascular thrombosis. Raised concentrations of crosslinked fibrin degradation products (XDP) are found in intravascular coagulation which accompanies a wide range of conditions. They are not specific for venous thromboembolism, but a normal concentration might be expected to exclude venous thromboembolic disease.
All inpatients with a suspected diagnosis of pulmonary thromboembolism referred for ventilation perfusion lung scans over a one year period were studied. Ventilation images Group. 1990 . ISBN 0-7462-0091-9.
As one would expect from these authors the microphotographs are outstanding and the publishers have done them proud. In some of the previous editions of this series the reproduction has been too small and too blurred, but in this edition the photomicrographs are produced at four or five to the page and the cytology of the cytoplasm and the nucleus, together with reproduction of the colour, is crisp and clear.
It was thanks to their previous book, first published in 1957 by another publisher, Cytology of Effusions and Cerebrospinal Fluid (now out of print), that I was persuaded to use May Grunwald-Giemsa stain on fluids, and for this I am very grateful. It has taken them a long time to update the original book but I think that the delay has been very worthwhile as the present book is yards ahead of its nearest competitor.
The only negative words I have to say about this atlas is that it costs too much. I know that colour printing is expensive but the price of £75 puts it out of the range of individual purchasers and this is a shame. I suggest that if the publishers halved the price they would sell more than twice the number of copies. Being that as it may, no cytopathology department should be without this atlas.
DH 
